NEW YORK (GenomeWeb News) — NeoClone Biotechnology has received a $750,000 Phase II Small Business Innovation Research grant from the National Institutes of Health to help it continue developing an antibody microarray for ovarian cancer, the company said this week.
The funding, administered through the National Cancer Institute, will pay for continued research and new equipment and staff for its Madison, Wis., labs.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A fire at a Manchester hospital may have destroyed lab equipment and data, the Guardian reports.

Researchers generate a genetic database from skeletal remains from the 1845 Franklin Expedition to the Arctic, Live Science reports.

Researchers in China have begun another trial using CRISPR/Cas9 approaches in cancer patients, according to the Wall Street Journal.

In Science this week: human DNA found in sediments from archeological sites lacking bones, and more.